Eleven studies (2,183 patients) were identified, 9 were RCTs and 2 were non-equivalent control group designs. Three studies (378 patients) evaluated rehabilitation for geriatric patients, the other 8 (1,805 patients) evaluated rehabilitation for stroke patients. Not all studies are included in the meta-analyses.
Survival:There was a significant difference in the odds of survival at discharge in favour of the rehabilitation group compared to the control group (P<0.01). The overall odds ratio was 1.46 (99% CI: 1.13, 1.78). There was no significant difference between groups at follow-up (calculated as the odds of survival between discharge and follow-up). Tests for heterogeneity indicated a constant treatment effect at both time periods.
Discharge location:significantly more patients from rehabilitation programmes return to their home at discharge (P<0.001) and remain there during follow-up (P<0.001). The odds ratio was 2.08% (99% CI: 1.81, 2.35) at discharge and 1.87 (99% CI: 1.57, 2.17) at follow-up. Tests for heterogeneity indicated a constant treatment effect at both time periods.
Functional ability:rehabilitation patients had significantly higher functional ability at discharge as rated by both the Stouffer (P<0.01) and Fisher (P<0.001) combined test. The results at follow-up were not significant. Tests for homogeneity were not significant.
To estimate the effect of publication bias, the 'fail-safe N' was calculated, this is the number of unpublished studies confirming the null hypothesis required to offset the results obtained. For survival at discharge, the number of studies required is 13, and, for functional ability at discharge, the number of studies required is 60.